Skip to main content
. 2018 Jun 4;5(6):e301–e308. doi: 10.1016/S2352-3018(18)30048-1

Table.

Characteristics of individuals enrolled in the UK CHIC study by year of cohort entry

Not linked to HARS (2000–04 [n=951]) 10 year cohort (2000–04 [n=12 811]) 5 year cohorts
2000–03 (n=9954) 2004–07 (n=11 259) 2008–09 (n=5318)
Age (years)
<30 283 (29·8%) 4004 (31·3%) 3182 (32·0%) 3344 (29·7%) 1414 (26·6%)
30–39 409 (43·0%) 5698 (44·5%) 4458 (44·8%) 4669 (41·5%) 2030 (38·2%)
40–49 165 (17·4%) 2239 (17·5%) 1650 (16·6%) 2379 (21·1%) 1324 (24·9%)
≥50 82 (8·6%) 870 (6·8%) 664 (6·7%) 867 (7·7%) 550 (10·3%)
Sex
Men 567 (59·6%) 8396 (65·5%) 6565 (66·0%) 7416 (65·9%) 3686 (69·3%)
Women 373 (39·2%) 4415 (34·5%) 3389 (34·0%) 3843 (34·1%) 1632 (30·7%)
Ethnicity
White 344 (36·2%) 5646 (44·1%) 4399 (44·2%) 5106 (45·4%) 2543 (47·8%)
Black 341 (35·9%) 5660 (44·2%) 4334 (43·5%) 4914 (43·6%) 2087 (39·2%)
Other or unknown 266 (28·0%) 1505 (11·7%) 1221 (12·3%) 1239 (11·0%) 688 (12·9%)
Mode of HIV acquisition
Sex between men 257 (27·0%) 5157 (40·3%) 4054 (40·7%) 4617 (41·0%) 2205 (41·5%)
Heterosexual 396 (41·6%) 6343 (49·5%) 4873 (49·0%) 5477 (48·6%) 2355 (44·3%)
Other or unknown 298 (31·3%) 1311 (10·2%) 1027 (10·3%) 1165 (10·3%) 758 (14·3%)
Newly diagnosed 723 (76·0%) 9888 (77·2%) 7948 (79·8%) 8110 (72·0%) 3737 (70·3%)
CD4 count (cells per μL)
<200 142 (14·9%) 2838 (22·2%) 2226 (22·4%) 2582 (22·9%) 1115 (21·0%)
201–350 83 (8·7%) 1998 (15·6%) 1463 (14·7%) 2101 (18·7%) 1057 (19·9%)
>350 199 (20·9%) 3414 (26·6%) 2509 (25·2%) 3833 (34·0%) 2081 (39·1%)
Data not available 527 (55·4%) 4561 (35·6%) 3756 (37·7%) 2743 (24·4%) 1065 (20·0%)
Viral load (log10copies per mL) 4·2 (2·6–5·0) 4·3 (3·1–5·1) 4·4 (3·3–5·1) 4·2 (2·8–5·0) 4·0 (2·5–4·9)

Data are n (%), or median (IQR). CHIC=Collaborative HIV Cohort. HARS=HIV and AIDS Reporting System.